
Temporary Medicare Benefits Schedule (MBS) items in response to Coronavirus (COVID-19) 011-20031903

-   Background
-   References
-   Resources
-   Training & Support

[Expand/Collapse all sections]Expand all

This page contains FAQ tables, item numbers for COVID-19 vaccine support
services, Services Australia website and external links.

MBS items and assessing - FAQs

Table 1

+-----------------------------------+-----------------------------------+
| Question                          | Answer                            |
+-----------------------------------+-----------------------------------+
| Where can I find information      | All of the items are available on |
| about the telehealth and          | MBS Online. See the telehealth    |
| telephone items?                  | information on the home page.     |
+-----------------------------------+-----------------------------------+
| Can health professionals bill a   | Yes, normal attendance items can  |
| normal attendance item to attend  | be billed if the services         |
| to a patient with suspected       | performed meet the requirements   |
| COVID-19?                         | in the item descriptor.           |
+-----------------------------------+-----------------------------------+

Assignment of benefit requirements during COVID-19 - FAQs

Table 2

+-----------------------------------+-----------------------------------+
| Enquirer                          | Question and answer               |
+-----------------------------------+-----------------------------------+
| Where can health professionals    | The Services Australia website    |
| find more information about the   | provides information on what is   |
| requirements of an email          | required where a health           |
| agreement for an assignment of    | professional enters into an email |
| benefit?                          | agreement.                        |
|                                   |                                   |
|                                   | See Bulk billing a telehealth     |
|                                   | video consultation                |
+-----------------------------------+-----------------------------------+
| Can I process a manual bulk bill  | Yes, the Department of Health and |
| claim during COVID-19 when there  | Aged Care has confirmed that      |
| is no patient signature?          | verbal consent from the patient   |
|                                   | is sufficient where reasonable    |
|                                   | efforts have been made to obtain  |
|                                   | a signature.                      |
|                                   |                                   |
|                                   | Manual bulk bill claims received  |
|                                   | during COVID-19 can be accepted   |
|                                   | and processed with or without a   |
|                                   | patient signature.                |
|                                   |                                   |
|                                   | Note: claims received with a date |
|                                   | of lodgement from 13 March 2020   |
|                                   | can be accepted, where the        |
|                                   | following has been provided:      |
|                                   |                                   |
|                                   | -   A completed DB1 header,       |
|                                   |     signed by the health          |
|                                   |     professional and witness      |
|                                   | -   An assignment of benefit form |
|                                   |     stating why the patient is    |
|                                   |     unable to sign. For example,  |
|                                   |     COVID-19, risk of exposure to |
|                                   |     COVID-19, verbal agreement,   |
|                                   |     telehealth, phone consult     |
|                                   |                                   |
|                                   | Health professionals should keep  |
|                                   | their own record that the patient |
|                                   | agreed or acknowledged the        |
|                                   | service was provided, and that    |
|                                   | the Medicare benefit could be     |
|                                   | paid directly to them.            |
|                                   |                                   |
|                                   | See Bulk bill claims in Medicare. |
+-----------------------------------+-----------------------------------+
| Can I process a bulk bill         | Yes, the same temporary policy    |
| adjustment during COVID-19 when   | applies for manual bulk bill      |
| there is no patient signature?    | claims and latter day adjustments |
|                                   | (see above). See Bulk bill latter |
|                                   | day adjustment (LDA) claims in    |
|                                   | Medicare.                         |
+-----------------------------------+-----------------------------------+

COVID-19 vaccine suitability assessments

Table 3

+-----------------------+-----------------------+-----------------------+
| Service               | General practitioner  | Medical practitioner  |
+-----------------------+-----------------------+-----------------------+
| First dose MMM 1      | 93624 (business       | 93626 (business       |
|                       | hours)                | hours)                |
|                       |                       |                       |
|                       | 93634 (after hours)   | 93636 (after hours)   |
+-----------------------+-----------------------+-----------------------+
| First dose MMM 2-7    | 93625 (business       | 93627 (business       |
|                       | hours)                | hours)                |
|                       |                       |                       |
|                       | 93635 (after hours)   | 93637 (after hours)   |
+-----------------------+-----------------------+-----------------------+
| Second or subsequent  | 93644 (business       | 93646 (business       |
| dose MMM 1            | hours)                | hours)                |
|                       |                       |                       |
|                       | 93653 (after hours)   | 93655 (after hours)   |
+-----------------------+-----------------------+-----------------------+
| Second or subsequent  | 93645 (business       | 93647 (business       |
| dose MMM 2-7          | hours)                | hours)                |
|                       |                       |                       |
|                       | 93654 (after hours)   | 93656 (after hours)   |
+-----------------------+-----------------------+-----------------------+
| Flag fall             | 90005                 | 90005                 |
+-----------------------+-----------------------+-----------------------+
| In-depth patient      | 10660                 | 10661                 |
| assessment            |                       |                       |
+-----------------------+-----------------------+-----------------------+
| Booster incentive     | 93666                 | 93666                 |
+-----------------------+-----------------------+-----------------------+

COVID-19 vaccine suitability by remote supervision

Table 4

+-----------------------+-----------------------+-----------------------+
| Service               | MMM 1 location        | MMM 2-7 location      |
+-----------------------+-----------------------+-----------------------+
| Off-site COVID-19     | 93660                 | 93661                 |
| vaccine suitability   |                       |                       |
| assessment by remote  |                       |                       |
| supervision, on       |                       |                       |
| behalf of the medical |                       |                       |
| practitioner          |                       |                       |
+-----------------------+-----------------------+-----------------------+

Co-claiming examples for COVID-19 vaccine suitability assessment services

Example 1 - no text is supplied with claim

A GP is co-claiming:

-   a general attendance item 23
-   monitoring and support CDM item 10997
-   2 x bulk bill incentives item 10991
-   COVID-19 Vaccine Suitability Assessment item 93625

Actions:

Item 93625 and consultation item 23 restrict. Text is needed to support
payment

QITI PF11 Item Restrictions shows pay High

-   Reject item 93625 because it has a lower benefit than item 23

Item 10991 restricts with item 93625. Items 23 and 10997 are eligible
for a bulk bill incentive

-   Pay 2 x item 10991

Item 10997 does not restrict. No text is needed to allow payment

-   Pay item 10997

Table 5: this table shows the processing requirements for Example 1.

  ------- ----------------------------------------- ----------------- ------------- ------ ----------------
  Item    Description                               Date of service   MBS benefit   Text   Pay/reject
  93625   COVID-19 vaccine suitability assessment   31/03/2021        $0.00         Nil    Reject RSN 159
  23      Consultation                              31/03/2021        $38.75        Nil    Pay
  10997   CDM monitoring and support                31/03/2021        $12.40        Nil    Pay
  10991   Bulk bill incentive                       31/03/2021        $9.80         n/a    Pay
  10991   Bulk bill incentive                       31/03/2021        $9.80         n/a    Pay
  ------- ----------------------------------------- ----------------- ------------- ------ ----------------

Example 2 - text is supplied with claim

A medical practitioner is co-claiming:

-   a general attendance item 52
-   monitoring and support CDM item 10997
-   3 x bulk bill incentives item 10991
-   COVID-19 Vaccine Suitability Assessment item 93627

Actions:

Item 93627 and item 52 restrict. Text is needed to support payment

-   Pay both items, text is supplied

Item 10991 restricts with item 93627. Items 52 and 10997 are eligible
for a bulk bill incentive

-   Pay 2 x item 10991
-   Reject 1 x item 10991 because the COVID-19 Vaccine Suitability
    Assessment items is not eligible for a bulk bill incentive

Item 10997 does not restrict. No text is needed to allow payment

-   Pay item 10997

Table 6: this table shows the processing requirements for Example 2.

  ------- ----------------------------------------- ----------------- ------------- ---------------------------- ----------------
  Item    Description                               Date of service   MBS benefit   Text                         Pay/reject
  93625   COVID-19 vaccine suitability assessment   31/03/2021        $38.80        Nil                          Pay PI 42
  52      Consultation                              31/03/2021        $38.75        Separate issue – unrelated   Pay
  10997   CDM monitoring and support                31/03/2021        $12.40        Nil                          Pay
  10991   Bulk bill incentive                       31/03/2021        $9.80         n/a                          Pay
  10991   Bulk bill incentive                       31/03/2021        $9.80         n/a                          Pay
  10991   Bulk bill incentive                       31/03/2021        $0.00         n/a                          Reject RSN 529
  ------- ----------------------------------------- ----------------- ------------- ---------------------------- ----------------

Services Australia website

Changes to MBS items (coronavirus (COVID-19) response)

Getting help during coronavirus (COVID-19)

Bulk bill payments to health professionals

Bulk billing a telehealth video consultation

Coronavirus information for health professionals

Billing multiple MBS items - Education guide

External links

Department of Health and Aged Care

COVID-19 National Health Plan - Primary Health - MBS Pathology
(Microbiology) Test for COVID-19 and Influenza

Who can get vaccinated

Third dose of COVID-19 vaccine recommended for people who are severely
immunocompromised

Fact sheet Coronavirus (COVID-19) National Health Plan

ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination

MBS Online factsheets

MBS Online

MBS interpretation - AskMBS Email Advice Service

MBS Telehealth Services from 1 July 2022

Assessment for a COVID-19 oral anti-viral medication

Cardiac magnetic resonance imaging (MRI) for myocarditis associated with
mRNA COVID-19 vaccination

MBS COVID-19 Management Support Service

FAQ – Bulk Billed MBS patient COVID-19 Vaccine Suitability Assessment
Service

Additional 10 MBS Mental Health Sessions factsheet

Extending Mental Health Support for Aged Care Residents During COVID-19

Nicotine and Smoking Cessation Counselling MBS Services

Claiming Microbiology Tests for SARS-CoV-2 (COVID-19) factsheet

Extension of SARS-CoV-2 (COVID-19) Pathology Items - 1 July 2022

                                   

-   Services Australia ABN 90 794 605 008 
